Global Cell Counting Market Report and Forecast 2025-2034

Global Cell Counting Market Outlook

The global cell counting market attained a value of USD 12.25 billion in 2024. The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 7.2% to reach a value of USD 22.81 billion by 2034.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Demand in Hospitals and Diagnostic Laboratories to Augment the Growth of the Cell Counting Industry

During the projection period, hospitals and diagnostic laboratories are estimated to observe a significant growth. This can be attributed to an increase in capital expenditure for the development of cell culture-based vaccines and the rapid expansion of the pharmaceutical industry. Additionally, rising government policies promoting stem cell development and research and the widespread usage of cell counting in medical operations are expected to provide a boost to the overall demand for cell counting in hospitals and diagnostic laboratories over the coming years. These factors are predicted to catalyse the industry growth in the forecast period.

The Asia Pacific to Account for a Significant Market Share of the Global Cell Counting Industry

The Asia Pacific is predicted to hold a significant share in the cell counting industry in the forecast period. This is attributable to the growing geriatric population, increased expenditure on research and development by the leading market players and public institutions, and improved healthcare infrastructure. Moreover, the market growth in the region can be associated with the increase in the number of proteomics and genomics researchers, as well as heightened investments by pharmaceutical and biotechnology organisations in the region. In addition, the presence of an array of medical research and biopharmaceutical businesses is anticipated to drive the market growth in the coming years.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Cell Counting: Market Segmentation

Cell counting is a technology for counting cells in medical applications that are used in both research and clinical settings. In addition, cell counting is essential in cytometry and is used in research to assess the number of reagents and chemicals required in a solution. Thus, cell counting provides the quantification of cells and it is increasingly utilised in clinical diagnosis and treatment procedures. For instance, the number of red blood cells and white blood cells is required by physicians to determine the health condition of a patient.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By product type, the industry is segmented into:

• Instruments
• Consumables and Accessories

Among these, the instruments segment is further divided, based on type, into spectrophotometers, flow cytometers, haematology analysers, and cell counters, among others.

Also, the consumables and accessories segment is further categorised, based on type, into media, sera, and reagents, and assay kits, among others.

The market can be broadly categorised, based on end use, into:

• Hospitals and Diagnostic Laboratories
• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Others

The EMR report looks into the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Rising Incidences of Cancer and Other Cardiovascular Diseases to Bolster the Growth of the Global Cell Counting Industry

The growing prevalence of cancer, AIDS, and other cardiovascular disorders around the world is anticipated to propel the worldwide cell counting industry growth. Moreover, the increasing geriatric population, which is more susceptible to chronic illnesses, is also predicted to contribute to the industry growth. Additionally, rising government initiatives towards the funding of stem cell research are estimated to bolster the market growth. Furthermore, with the rapid technological advancements, the market is predicted to be driven by innovations in existing products as well as the launch of new data visualisation and analysis tools. In addition, increased corporate expenditure for cell-based research as well as the development of new informatics solutions and image analysis devices are predicted to aid the market expansion in the coming years. However, the high pricing of advanced cell counting systems may hinder the market growth.

Key Industry Players in the Global Cell Counting Market

The report presents a detailed analysis of the following key players in the global cell counting market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc. 
• Beckman Coulter, Inc.
• PerkinElmer Inc.
• Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report